Tatva Chintan Pharma Chem Shareholding Pattern
- Market cap
- ₹4,194 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹1,290.82 – ₹2,420.28
As of Jun 2026, promoters held 48.50% of Tatva Chintan Pharma Chem, foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 9 October 2026. How this data is compiled.
Tatva Chintan Pharma Chem shareholding pattern — frequently asked questions
What is the promoter holding in Tatva Chintan Pharma Chem?
Promoters held 48.50% of Tatva Chintan Pharma Chem as of Jun 2026.
How much do FIIs hold in Tatva Chintan Pharma Chem?
Foreign institutional investors held 18.40% of Tatva Chintan Pharma Chem as of Jun 2026.
How much do domestic institutions hold in Tatva Chintan Pharma Chem?
Domestic institutional investors, including mutual funds and insurers, held 14.20% of Tatva Chintan Pharma Chem as of Jun 2026; mutual funds alone held 8.50%.
Who owns Tatva Chintan Pharma Chem?
As of Jun 2026, Tatva Chintan Pharma Chem's shareholders were promoters (48.50%), foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%, as filed with the stock exchanges.
Same Data For Peers
- Themis Medicare Limited shareholding pattern
- Syngene International Limited shareholding pattern
- Thyrocare Technologies Limited shareholding pattern
- Syncom Formulations (India) Limited shareholding pattern
- Torrent Pharmaceuticals Limited shareholding pattern
- Suven Life Sciences Limited shareholding pattern
Trade Tatva Chintan Pharma Chem With ATS
Track TATVA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.